GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Sale Of Investment

Renhe Pharmacy Co (SZSE:000650) Sale Of Investment : ¥7,505 Mil (TTM As of Sep. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Sale Of Investment?

Renhe Pharmacy Co's sale of investment for the three months ended in Sep. 2024 was ¥1,738 Mil. It means Renhe Pharmacy Co gained ¥1,738 Mil from selling investments. Renhe Pharmacy Co's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was ¥7,505 Mil.

Compared with last quarter (¥1,282 Mil in Jun. 2024 ), Renhe Pharmacy Co gained more money from selling investments in Sep. 2024 (¥1,738 Mil).


Renhe Pharmacy Co Sale Of Investment Historical Data

The historical data trend for Renhe Pharmacy Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Sale Of Investment Chart

Renhe Pharmacy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,034.20 10,753.29 12,347.86 7,662.89 6,124.05

Renhe Pharmacy Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,491.24 2,545.85 1,938.88 1,282.45 1,737.63

Renhe Pharmacy Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7,505 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renhe Pharmacy Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines